CNJ-294 is an intermediate in the synthesis of Capmatinib ( HY-13404 ) and a metabolite of Capmatinib ( HY-13404 ).
Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Others | Products > Signaling Pathways > Drug Intermediate | Products > Signaling Pathways > Drug Metabolite
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.